These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15270584)

  • 21. Prostatic conformal brachytherapy: 125I/103Pd postoperative dosimetric analysis.
    Merrick GS; Butler WM; Dorsey AT; Walbert HL
    Radiat Oncol Investig; 1997; 5(6):305-13. PubMed ID: 9436248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salvage reimplantation in patient with local recurrent prostate carcinoma after brachytherapy with three dimensional computed tomography-guided permanent pararectal implant.
    Koutrouvelis P; Hendricks F; Lailas N; Gil-Montero G; Sehn J; Khawand N; Bondy H; Katz S
    Technol Cancer Res Treat; 2003 Aug; 2(4):339-44. PubMed ID: 12892517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapy.
    Buyyounouski MK; Horwitz EM; Uzzo RG; Price RA; McNeeley SW; Azizi D; Hanlon AL; Milestone BN; Pollack A
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1383-91. PubMed ID: 15275723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of edema on planning 125I and 103Pd prostate implants.
    Yue N; Dicker AP; Nath R; Waterman FM
    Med Phys; 1999 May; 26(5):763-7. PubMed ID: 10360539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MR and CT image fusion for postimplant analysis in permanent prostate seed implants.
    Polo A; Cattani F; Vavassori A; Origgi D; Villa G; Marsiglia H; Bellomi M; Tosi G; De Cobelli O; Orecchia R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1572-9. PubMed ID: 15590189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Permanent implant prostate cancer brachytherapy: 2013 state-of-the art].
    Cosset JM; Hannoun-Lévi JM; Peiffert D; Delannes M; Pommier P; Pierrat N; Nickers P; Thomas L; Chauveinc L
    Cancer Radiother; 2013 Apr; 17(2):111-7. PubMed ID: 23478488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study.
    Martin T; Baltas D; Kurek R; Röddiger S; Kontova M; Anagnostopoulos G; Dannenberg T; Buhleier T; Skazikis G; Tunn U; Zamboglou N
    Strahlenther Onkol; 2004 Apr; 180(4):225-32. PubMed ID: 15057433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Moving toward focal therapy in prostate cancer: dual-isotope permanent seed implants as a possible solution.
    Todor DA; Barani IJ; Lin PS; Anscher MS
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):297-304. PubMed ID: 21536392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes.
    Mangili P; Stea L; Cattani F; Lappi S; Giglioli F; Calamia E; Ziglio F; Martinelli R; Longobardi B
    Radiother Oncol; 2004 Apr; 71(1):13-21. PubMed ID: 15066291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of image coregistration in salvage prostate brachytherapy.
    Bice WS; Freeman JE; Russell LF; Case GD; Dubois DF; Prete JJ; Prestidge BR
    Tech Urol; 2000 Jun; 6(2):151-6. PubMed ID: 10798817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosimetric effects of needle divergence in prostate seed implant using 125I and 103Pd radioactive seeds.
    Nath S; Chen Z; Yue N; Trumpore S; Peschel R
    Med Phys; 2000 May; 27(5):1058-66. PubMed ID: 10841410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Technique of intraoperative planning in prostatic brachytherapy with permanent implants of 125I or 103Pd].
    Prada Gómez PJ; Juan Rijo G; Hevia Suarez M; Abascal García JM; Abascal García R
    Arch Esp Urol; 2002 Dec; 55(10):1217-23; discussion 1223-4. PubMed ID: 12611219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging.
    Zelefsky MJ; Cohen G; Zakian KL; Dyke J; Koutcher JA; Hricak H; Schwartz L; Zaider M
    Cancer J; 2000; 6(4):249-55. PubMed ID: 11038145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variability of prostate brachytherapy pre-implant dosimetry: a multi-institutional analysis.
    Merrick GS; Butler WM; Wallner KE; Blasko JC; Michalski J; Aronowitz J; Grimm P; Moran BJ; McLaughlin PW; Usher J; Lief JH; Allen ZA
    Brachytherapy; 2005; 4(4):241-51. PubMed ID: 16344253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of brachytherapy in the definitive management of prostate cancer.
    Crook J
    Cancer Radiother; 2011 Jun; 15(3):230-7. PubMed ID: 21514199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brachytherapy in patients with small prostate glands.
    Loblaw DA; Wallner K; Dibiase S; Russell K; Blasko J; Ellis W
    Tech Urol; 2000 Jun; 6(2):64-9. PubMed ID: 10798802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosimetric analysis of urinary morbidity following prostate brachytherapy (125I vs. 103Pd) combined with external beam radiation therapy.
    Chen CT; Waterman FM; Valicenti RK; Gomella LG; Strup SE; Dicker AP
    Int J Cancer; 2001; 96 Suppl():83-8. PubMed ID: 11992390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Difference in rectal dosimetry between pre-plan and post-implant analysis in transperineal interstitial brachytherapy for prostate cancer.
    Ishiyama H; Kitano M; Satoh T; Niibe Y; Uemae M; Fujita T; Baba S; Hayakawa K
    Radiother Oncol; 2006 Feb; 78(2):194-8. PubMed ID: 16414135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Twelve-month prostate-specific antigen values and perineural invasion as strong independent prognostic variables of long-term biochemical outcome after prostate seed brachytherapy.
    Ding W; Lee J; Chamberlain D; Cunningham J; Yang L; Tay J
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):962-7. PubMed ID: 22494584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of day 0 and day 14 dosimetry for permanent prostate implants using stranded seeds.
    McLaughlin P; Narayana V; Pan C; Berri S; Troyer S; Herman J; Evans V; Roberson P
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):144-50. PubMed ID: 16243441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.